CL2020001426A1 - Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo. - Google Patents

Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo.

Info

Publication number
CL2020001426A1
CL2020001426A1 CL2020001426A CL2020001426A CL2020001426A1 CL 2020001426 A1 CL2020001426 A1 CL 2020001426A1 CL 2020001426 A CL2020001426 A CL 2020001426A CL 2020001426 A CL2020001426 A CL 2020001426A CL 2020001426 A1 CL2020001426 A1 CL 2020001426A1
Authority
CL
Chile
Prior art keywords
eye
posterior segment
acid
ophthalmic composition
treat diseases
Prior art date
Application number
CL2020001426A
Other languages
English (en)
Spanish (es)
Inventor
Gañán Maria Isabel Delgado
Nortes Xavier Capdevila
Aquilué Javier Sanagustín
Original Assignee
Salvat Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salvat Lab Sa filed Critical Salvat Lab Sa
Publication of CL2020001426A1 publication Critical patent/CL2020001426A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL2020001426A 2017-12-04 2020-05-28 Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo. CL2020001426A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17382832 2017-12-04

Publications (1)

Publication Number Publication Date
CL2020001426A1 true CL2020001426A1 (es) 2020-11-06

Family

ID=60673756

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2020001426A CL2020001426A1 (es) 2017-12-04 2020-05-28 Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo.

Country Status (24)

Country Link
US (1) US20200390729A1 (https=)
EP (1) EP3720428B1 (https=)
JP (1) JP7846501B2 (https=)
KR (1) KR102756155B1 (https=)
CN (1) CN111542316A (https=)
AU (1) AU2018378981B2 (https=)
BR (1) BR112020011160A2 (https=)
CA (1) CA3083835A1 (https=)
CL (1) CL2020001426A1 (https=)
DK (1) DK3720428T3 (https=)
ES (1) ES2941036T3 (https=)
FI (1) FI3720428T3 (https=)
HR (1) HRP20230319T1 (https=)
HU (1) HUE061852T2 (https=)
MA (1) MA50991B1 (https=)
MX (1) MX2020005809A (https=)
MY (1) MY205498A (https=)
PH (1) PH12020550722A1 (https=)
PL (1) PL3720428T3 (https=)
PT (1) PT3720428T (https=)
SG (1) SG11202004940VA (https=)
SI (1) SI3720428T1 (https=)
WO (1) WO2019110416A1 (https=)
ZA (1) ZA202003944B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202300017430A1 (it) * 2023-08-22 2025-02-22 Service Biotech srl Soluzione oftalmica in forma di collirio contenente una isoforma umana ricombinante di manganese superossido dismutasi (rmnsod) per la cura di patologie dell’occhio
CN117257963B (zh) * 2023-11-02 2024-07-16 广州准优生物科技有限公司 含脐带间充质干细胞外泌体的眼用药剂及其制备方法和用途
CN117643573B (zh) * 2024-01-29 2024-05-03 天津医科大学眼科医院 一种可递送药物至眼后节的纳米滴眼液及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51421B1 (en) * 1980-08-01 1986-12-24 Smith & Nephew Ass Ophthalmic compositions containing triamterene
US9198886B2 (en) * 2006-08-16 2015-12-01 Pedro Cuevas Sánchez Use of 2,5-dihydroxybenzene for the treatment of ocular diseases
JP2015500213A (ja) 2011-11-30 2015-01-05 ザイジェン インフラメーション リミテッド 眼乾燥症候群を処置するためのｊｎｋシグナル伝達経路の細胞透過性ペプチド阻害剤の使用
EP2777699B1 (en) 2012-02-02 2017-03-29 Invesfovea S.L. Diethylamine-2,5-dihydroxybenzenesulfonate for the treatment of age-related macular degeneration
CA2866405A1 (en) 2012-03-05 2013-09-12 Wayne State University Identification of channelopsin-2 (chop2) mutations and methods of use
RU2014140116A (ru) 2012-04-24 2016-06-10 Тромбодженикс Н.В. Антитела против pdgf-c
EP2875811A1 (en) 2013-11-26 2015-05-27 Luis Antonio Outeirino Miguez Use of dobesilate for treating ocular haemorrhages

Also Published As

Publication number Publication date
SI3720428T1 (sl) 2023-05-31
CA3083835A1 (en) 2019-06-13
ES2941036T3 (es) 2023-05-16
EP3720428A1 (en) 2020-10-14
WO2019110416A1 (en) 2019-06-13
KR102756155B1 (ko) 2025-01-20
KR20200096569A (ko) 2020-08-12
ZA202003944B (en) 2022-12-21
PH12020550722A1 (en) 2021-02-15
CN111542316A (zh) 2020-08-14
JP7846501B2 (ja) 2026-04-15
HRP20230319T1 (hr) 2023-05-12
AU2018378981A1 (en) 2020-07-16
EP3720428B1 (en) 2023-01-11
BR112020011160A2 (pt) 2020-11-17
MX2020005809A (es) 2020-08-20
HUE061852T2 (hu) 2023-08-28
DK3720428T3 (da) 2023-03-20
US20200390729A1 (en) 2020-12-17
JP2021505554A (ja) 2021-02-18
MA50991B1 (fr) 2023-03-31
FI3720428T3 (fi) 2023-03-30
MA50991A (fr) 2020-10-14
PT3720428T (pt) 2023-04-03
PL3720428T3 (pl) 2023-05-08
MY205498A (en) 2024-10-23
SG11202004940VA (en) 2020-06-29
AU2018378981B2 (en) 2024-10-24

Similar Documents

Publication Publication Date Title
MX2016014634A (es) Compuestos para el tratamiento de enfermedades y trastornos oftalmicos.
EP4491229A3 (en) Coding rna administered into the suprachoroidal space in the treatment of ophtalmic diseases
MX393855B (es) Terapia de combinación que comprende un inhibidor de raf y trametinib
MX2010003774A (es) Formulaciones oftalmicas acuosas.
BR112014008789A2 (pt) prevenção e tratamento de condições oculares
IL273531A (en) Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
EP4306523A3 (en) Imidazoquinoline compounds and uses thereof
MX2019013799A (es) Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo.
EP4324454A3 (en) Cross-linking agents and associated methods
AR088585A1 (es) Un medicamento para tratar la enfermedad del ojo anterior
MX2020006309A (es) Fórmulaciones de parasiticida de isoxazolina y métodos para el tratamiento de la blefaritis.
CL2020001426A1 (es) Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo.
AU2017261303A1 (en) Ophthalmic compositions
EA202191684A1 (ru) Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии
WO2015048188A3 (en) Modified fibroblast growth factors for the treatment of ocular disorders
MX2020012011A (es) Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular.
AR092842A1 (es) Tratamiento de enfermedades inflamatorias oculares usando laquinimod
AR106691A1 (es) Formulaciones oftálmicas de escualamina
WO2017152129A3 (en) Treatment of glaucoma and/or retinal diseases and formulations useful therefore
AR110947A1 (es) Tratamiento de degeneración de la retina mediante el uso de células progenitoras
EP4691493A3 (en) Compositions for treating eye diseases
MX2021014093A (es) Composiciones y metodos para tratar el mal de alzheimer y la enfermedad de parkinson.
MX2022006523A (es) Composicion que comprende budesonida para uso oftalmico.
MX2021007324A (es) Terapia oral con acido 6,8-bis-benciltio-octanoico.
AR106690A1 (es) Método para administrar escualamina o una sal farmacéuticamente aceptable a la esclerótica posterior y a la coroides del ojo